enbrel
wyeth indÚstria farmacÊutica ltda - antinflamatorios
nepexto
mylan laboratorios ltda - etanercepte - antinflamatorios
cimzia
ucb biopharma ltda. - certolizumabe pegol - antinflamatorios
cimzia
astrazeneca do brasil ltda - antinflamatorios
pylclari
curium pet france - piflufolastat (18f) - neoplasias prostáticas - radiofármaco de diagnóstico - este medicamento é apenas para uso diagnóstico. pylclari is indicated for the detection of prostate-specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high-risk pca prior to initial curative therapy,to localize recurrence of pca in patients with a suspected recurrence based on increasing serum prostate-specific antigen (psa) levels after primary treatment with curative intent. pylclari is indicated for use with positron emission tomography (pet).
remsima
celltrion healthcare distribuicao de produtos farmaceuticos dos brasil ltda - infliximabe - antinflamatorios
bio-manguinhos etanercepte
fundaÇÃo oswaldo cruz - etanercepte - antinflamatorios
reblozyl
bristol myers squibb pharma eeig - luspatercept - anemia; myelodysplastic syndromes; beta-thalassemia - outras preparações antianemic - reblozyl is indicated for the treatment of adult patients with transfusion-dependent anaemia due to very low, low and intermediate-risk myelodysplastic syndromes (mds) with ring sideroblasts, who had an unsatisfactory response to or are ineligible for erythropoietin-based therapy (see section 5. reblozyl is indicated in adults for the treatment of anaemia associated with transfusion dependent and non transfusion dependent beta thalassaemia (see section 5.
willentine
mawdsleys pharmaceuticals do brasil ltda - dicloridrato de trientina - moduladores do metabolismo e da digestao
bicalutamida tecnimede 150 mg comprimido revestido por película
tecnimede - sociedade técnico-medicinal, s.a. - bicalutamida - comprimido revestido por película - 150 mg - bicalutamida 150 mg - bicalutamide - genérico - duração do tratamento: longa duração